FDA approvals decline but drug innovation remains strong even among small sponsors
The US Food and Drug Administration (FDA) approved 126 innovator and biosimilar drugs in 2024, significantly lower than the 149 approvals in 2023.
The US Food and Drug Administration (FDA) approved 126 innovator and biosimilar drugs in 2024, significantly lower than the 149 approvals in 2023.
What's Your Reaction?
